Betamethasone Sodium Phosphate
- CAS No.151-73-5
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity Betamethasone Sodium Phosphate (CAS 151-73-5) supplied for pharmaceutical formulation and research. Meets USP standards with comprehensive COA.
Request Bulk PricingProduct Technical Details
Product Overview
Betamethasone Sodium Phosphate is a high-performance corticosteroid intermediate widely utilized in the pharmaceutical industry for the development of anti-inflammatory formulations. As a water-soluble salt derivative of betamethasone, this compound offers enhanced bioavailability and stability, making it a critical component for injectable solutions, ophthalmic preparations, and topical treatments. Our manufacturing process ensures exceptional purity levels, adhering to strict international pharmacopoeia standards including USP and EP guidelines.
We specialize in supplying this advanced organic synthesis product to licensed pharmaceutical manufacturers and research institutions globally. Each batch undergoes rigorous analytical testing to guarantee consistency in molecular structure and potency. The compound is characterized by its white or almost white crystalline powder appearance, ensuring ease of handling during downstream processing and formulation development.
Technical Specifications
Quality assurance is paramount in pharmaceutical supply chains. Our Betamethasone Sodium Phosphate is produced in GMP-compliant facilities with full traceability. The following table outlines the key analytical parameters and test results typical of our production batches:
| Items of Analysis | Standard of Analysis | Test Results |
|---|---|---|
| Appearance | White or almost white crystalline powder | Almost white crystalline powder |
| Identification | A: IR, B: TLC, C: Positive reaction | Conforms |
| Specific Rotation | +99°~+105° | +100.3° |
| Phosphate Ions | ≤1.0% | Conforms |
| Free Betamethasone | ≤1.0% | 0.6% |
| Water Content | ≤10.0% | 8.1% |
| Residual Solvents (Methanol) | ≤3000ppm | 146ppm |
| Residual Solvents (Acetone) | ≤5000ppm | 236ppm |
| Assay | 97.0-103.0% | 99.35% |
| Conclusion | Conforms to the requirements of USP 41 | |
Industrial Applications
This chemical entity serves as a vital active pharmaceutical ingredient (API) or intermediate in the production of various therapeutic agents. Its primary application lies in the management of allergic inflammation affecting the eyes, ears, nose, and skin. Due to its high solubility profile, it is particularly suited for parenteral formulations where rapid onset of action is required. Additionally, it functions effectively in dermatological creams and lotions designed for sensitive skin conditions.
For formulation scientists, this material offers a reliable performance benchmark. It acts as a drop-in replacement for existing supply chains requiring high-grade corticosteroid salts. The low residual solvent profile ensures safety in final drug products, minimizing toxicity risks during clinical trials and commercial production.
Quality Assurance and Storage
Maintaining the integrity of Betamethasone Sodium Phosphate requires strict adherence to storage protocols. The material should be kept in a ventilated, low-temperature, and dry environment to prevent hydrolysis or degradation. We provide a comprehensive Certificate of Analysis (COA) with every shipment, detailing batch-specific data such as molecular weight (516.41 g/mol) and boiling point characteristics.
Our commitment to quality extends beyond the product itself. We offer global manufacturing support, ensuring timely delivery and secure packaging for international logistics. Whether for large-scale commercial manufacturing or small-batch research projects, our team provides the technical documentation necessary for regulatory filings. Partner with us for a supply chain defined by transparency, compliance, and chemical excellence.
